2007 - a special anniversary year for Dräger

Drägerwerk AG100 years ago in October 1907, company founder, Johann Heinrich Dräger, was awarded a patent for the Pulmotor, the first mobile short-term respirator. This marked the birth of ventilation technology development at Dräger. Simple, reliable, and extremely effective, the apparatus - transported in a wooden casket - quickly became a standard piece of equipment used by rescue services throughout Germany.

It all began early in the 20th century, when, on a trip to England, Johann Heinrich Dräger witnessed a young man being pulled out the Thames and resuscitated using the traditional Schaeffer method. Still in London, Dräger then produced some initial sketches. Upon returning to Lübeck, he began developing a technical solution for a resuscitation machine. After a few more modifications, the result was "Dräger's Pulmotor, the first automatic oxygen resuscitation machine for artificial respiration", manufactured in the factory and construction institute for oxygen apparatus known at the time as Drägerwerk in Lübeck, Germany. In his memoirs, Johann Heinrich Dräger spoke of the Pulmotor as having enabled well over 1,000 officially attested resuscitations by March 1, 1917.

Successful attempts at resuscitating miners poisoned by carbon monoxide, for example, paid testament to the success of the oxygen machine just a short time after its market launch in 1908 - in defiance of the skeptics of positive pressure respiration. Dräger consequently started serial production which, even at that time, proved extremely successful in the United States. The first Dräger company on US soil was founded in the US in 1907, too: at 11 Broadway in New York City; shortly afterwards, the company was moved to Pittsburgh, PA, and renamed Draeger Oxygen Apparatus Company. Internationality and innovativeness have a long tradition at Dräger.

In the US, the Pulmotor respirator was bought mainly to equip rescue teams of mining companies (mine rescuers) and fire departments, hence Dräger's legendary reputation for breathing apparatus in the US: mine rescuers equipped with Dräger apparatus were known as Draegermen.

The Oxylog product family, which is still going strong today, superseded the successful Pulmotor in 1978. After the first applications of the Iron Lung in the fifties, long-term positive pressure ventilation was introduced. Today, this is fulfilled by the intensive care ventilators of the Evita family. All of these devices are based on the technical specifications of the Pulmotor. In fact, advancements in this technical innovation from the beginning of the 20th century are now not only used for emergency and long-term ventilation, but also in anesthesia and for home care.

For further information, please visit:
http://www.draeger.com

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...